Revised Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products Who Have Received Human-Derived Clotting Factor Concentrates

Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components, CBER, Biologics, Tissue

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2Vsgd1K